[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![PrismMarketView Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1257318598386696195.png) PRISM MarketView [@PrismMarketView](/creator/twitter/PrismMarketView) on x 4678 followers
Created: 2025-07-10 13:13:14 UTC

$NRIX surged XX% as Nurix Therapeutics ramps up progress in targeted protein degradation. With new CLL data, pivotal trials ahead, and expanded deals with Gilead $GILD and Sanofi $SNY, this biotech is gaining serious traction. Full Story: .@Nurix_Tx

![](https://pbs.twimg.com/media/Gvf6Tv0XgAAa4Y3.jpg)

XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1943297461558071750/c:line.svg)

**Related Topics**
[$sny](/topic/$sny)
[$gild](/topic/$gild)
[$nrix](/topic/$nrix)
[prism](/topic/prism)
[gilead sciences](/topic/gilead-sciences)
[stocks healthcare](/topic/stocks-healthcare)
[sanofi](/topic/sanofi)

[Post Link](https://x.com/PrismMarketView/status/1943297461558071750)